Jumpcan Pharmaceutical completes share buyback, shareholder unpledges stock

Hubei Jumpcan Pharmaceutical completed its share repurchase, acquiring 914,200 shares for RMB 25,005,955. The shares will be used for employee stock ownership or equity incentives.

Controlling shareholder Jiangsu Jumpcan Holdings Group unpledged 65,200,000 shares, reducing its total pledged holdings to 43,000,000 shares, representing 10.32% of its total shares.